Eton Pharma announces positive results from bioequivalence study of ET-600 to treat central diabetes insipidus: Deer Park, Illinois Monday, March 17, 2025, 18:00 Hrs [IST] Eton Ph ...

Eton Pharmaceuticals (ETON) announced positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of ...

ET-600 is a proprietary formulation of desmopressin oral solution developed for the treatment of central diabetes insipidus.

One of the ways diabetes can affect the body is by overstimulating the sweat glands. Because of this, it's harder to maintain a steady internal body temperature. Extreme fluctuations in blood sugar ...

About nine out of ten people with diabetes have type 2 diabetes. The good news is that type 2 diabetes can be prevented or postponed by making healthy lifestyle choices. Diabetes is a lifelong ...

Furthermore, in a rat model of streptozotocin-induced diabetes, physical exercise has demonstrated a protective effect against cytokine-induced pancreatic β-cell death and has been shown to promote ...

The onset of diabetes is most common in people ages 45 to 64. Type 2 diabetes is the most common form of diabetes. It usually appears after the age of 45 but can occur at any age. The development ...

Diabetes Insipidus and ADH or Vasopressin: In patients with diabetes insipidus, there is a general deficiency of the hormone ADH or vasopressin. Nocturnal polyuria can also occur due to other ...

Blurry vision can be an early warning sign of diabetes. It's also a sign of advanced diabetic eye disease. If blood sugar goes uncontrolled, diabetes causes progressive damage to structures in the ...

Type 1 diabetes occurs when the immune system attacks pancreatic beta cells. Type 2 diabetes happens when the body cannot use insulin effectively. The two types differ in symptoms, causes ...

Common symptoms of type 2 diabetes may include extreme thirst and frequent urination. You may also experience blurry vision, tiredness, and slow-healing cuts or wounds. Many people with type 2 ...